INSERM, UMR U917, Equipe Labellisée Ligue Contre le Cancer, Faculté de Médecine, Rennes, France; Université Rennes 1, Rennes, France; CHU de Rennes, Hôpital Pontchaillou, Service ITeCH, Pôle de Biologie, Rennes, France.
INSERM, UMR U917, Equipe Labellisée Ligue Contre le Cancer, Faculté de Médecine, Rennes, France; Université Rennes 1, Rennes, France; CHU de Rennes, Hôpital Pontchaillou, Service ITeCH, Pôle de Biologie, Rennes, France; Etablissement Français du Sang Bretagne, Rennes, France.
Semin Cancer Biol. 2014 Feb;24:23-32. doi: 10.1016/j.semcancer.2013.08.001. Epub 2013 Aug 23.
Follicular lymphoma (FL) results from the malignant transformation of germinal center B cells and is characterized by recurrent genetic alterations providing a direct growth advantage or facilitating interaction with tumor microenvironment. In agreement, accumulating evidences suggest a dynamic bidirectional crosstalk between FL B cells and surrounding non-malignant cells within specialized tumor niches in both invaded lymph nodes and bone marrow. Infiltrating stromal cells, macrophages, and T/NK cell subsets either contribute to anti-tumor immune response, or conversely form a tumor supportive network promoting FL B cell survival, growth, and drug resistance. This review depicts the phenotypic heterogeneity and functional plasticity of the most important FL cell partners and describes their complex interplay. We also unravel how malignant B cells recruit and subvert accessory immune and stromal cells to trigger their polarization toward a supportive phenotype. Based on these observations, innovative therapeutic approaches have been recently proposed, in order to benefit from local anti-tumor immunity and/or to selectively target the protective cell niche.
滤泡性淋巴瘤 (FL) 源于生发中心 B 细胞的恶性转化,其特征是反复出现的遗传改变提供了直接的生长优势或促进与肿瘤微环境的相互作用。一致地,越来越多的证据表明,FL B 细胞与在入侵淋巴结和骨髓中的特定肿瘤龛内的周围非恶性细胞之间存在动态双向串扰。浸润的基质细胞、巨噬细胞和 T/NK 细胞亚群要么有助于抗肿瘤免疫反应,要么相反形成促进 FL B 细胞存活、生长和耐药性的肿瘤支持网络。这篇综述描绘了最重要的 FL 细胞伙伴的表型异质性和功能可塑性,并描述了它们的复杂相互作用。我们还揭示了恶性 B 细胞如何招募和颠覆辅助免疫和基质细胞,以触发它们向支持性表型的极化。基于这些观察结果,最近提出了创新的治疗方法,以便利用局部抗肿瘤免疫和/或选择性地靶向保护性细胞龛。